Clinical Trials Browser

Phase 1/2 × High-risk Leukemias × Other hematologic neoplasm × Clear all

NCT05304754 2025-04-06

PHINK

Phase 1/2 Active not recruiting

Other hematologic neoplasm

High-risk Leukemias